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The significance of ST segment shift with respect to coro- 
nary anatomy and hospital outcome was evaluated in 135 
patients with unstable angina. ST shift was evident in 44% 
of patients on admission electrocardiogram (ECG) and in 
66% on Halter monitor ECG. During hospitalization, 7% 
of patients had myocardial infarction, 4% died and 34% 
had urgent coronary revascularization. By comparing pa- 
tients with and without ST shift on admission ECG, an 
unfavorable outcome was found in 55% versus 25% (p < 
O.OOS), multivessel disease in 77% versus 63% (p < 0.05) 
and left main coronary artery stenosis in 22% versus 7% (p 
< 0.025). When patients with and without ST shift on Holter 
monitor ECG were compared, an unfavorable outcome was 
found in 48% versus 20% (p < O.OOS), multivessel disease in 
76% versus 54% (p < 0.01) and left main coronary stenosis 
in 18% versus 4% (p < 0.05). The duration of ST shift was 
also greater in patients with 1) unfavorable outcome (129 + 
136 versus 52 -+ 111 min, p < 0.01); 2) multivessel disease 
(98 -C 129 versus 36 -C 90 mitt, p < 0.01); and 3) left main 
stenosis (150 f 147 versus 67 f 114 min, p < 0.01). 
Holter electrocardiographic (ECG) monitoring reveals fre- 
quent asymptomatic episodes of ST segment shift in patients 
with stable angina (I-8). Given our current understanding of 
the pathophysiology of unstable angina (9-14), coupled with 
the advanced symptoms and significant cardiac event rate in 
patients with this syndrome (l5-18), it is not surprising that 
asymptomatic ST segment shift appears as a frequent feature 
of such patients (19-22). Although the outcome of unstable 
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A total of 593 episodes of ST shift were recorded by 
Holter monitor and only 8% were symptomatic; when 
compared with asymptomatic episodes, they were of longer 
duration (42 f 50 versus 16 + 27 mitt, p < 0.01) and had 
greater magnitude of ST shift (2.0 f 1.3 versus 1.3 -C 0.5 
mm, p < 0.01). Continuous blood pressure and heart rate 
recording in 446 episodes showed an increase in rate- 
pressure product at 20 and 10 min (9.4 f 2.7 x 103, p < 
0.01) before onset of ST shift as well as at the time of ST 
shift (9.3 f 2.8 x lo’, p < 0.01) as compared with the 2 h 
baseline value (9.0 f 2.3 x 103). 
Thus: 1) noninvasive tests can stratify patients with 
unstable angina into prognostic subsets with respect to 
hospital outcome and coronary anatomy; 2) episodes of ST 
shift associated with symptoms have a greater magnitude of 
ST shift and are of longer duration; and 3) myocardial 
ischemia, as demonstrated by onset of ST shift, may be 
mediated in part by increased myocardial oxygen demand 
as defined by an increase in rate-pressure product. 
(J Am Co11 Cardiol1989;13:1495-502) 
angina bears an important relation to coronary angiographic 
severity and complexity of disease (23,241, it is not feasible 
to catheterize all such patients, especially with limited health 
care resources. Thus a noninvasive technique that, applied 
early in the course of unstable angina, could identify those 
patients at increased risk would be helpful in assessing the 
need for angiographic studies. 
Recent studies (21,22) suggest that the presence of silent 
ST segment shift in patients with unstable angina is associ- 
ated with an unfavorable 1 and 6 month prognosis. Because 
such patients frequently require rapid decision-making dur- 
ing their current admission, it is important to know whether 
assessment of ST shift on an early Holter monitor ECG or 
admission ECG is of value in predicting unfavorable hospital 
outcome as well as angiographic severity of coronary artery 
disease. We therefore undertook the current prospective 
study to test the hypothesis that the presence of ST abnor- 
mality on admission ECG and the presence and duration of 
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ST segment shift detected during 24 h Holter monitoring 
early in the course of unstable angina predict angiographic 
severity of coronary artery disease and hospital outcome in 
a consecutive group of patients. We also assessed changes in 
heart rate and blood pressure before and during the time of 
onset of ST shift to gain insight into the pathophysiology of 
myocardial ischemia in our patients. 
Methods 
Study patients. Over a consecutive period of 28 months, 
196 patients with unstable angina were enrolled in the study. 
Unstable angina was defined as rapid acceleration of a 
previously established angina1 syndrome to include rest pain 
or prolonged ischemic chest pain of >20 min duration 
without evidence of acute myocardial infarction, as defined 
by typical evolutionary changes on the ECG in association 
with serum cardiac enzyme elevation (evidence of enzymatic 
rise 22 x upper normal limits). Individuals were enrolled in 
the study if they were seen within 24 h of the last episode of 
ischemic chest pain at rest. They were excluded if they were 
>75 years of age or had a debilitating illness, left bundle 
branch block or previous aortocoronary bypass surgery. Of 
the 196 patients, 24 subsequently had enzymatic evidence 
that the presenting event was due to myocardial infarction 
and were, therefore, excluded. All patients gave informed 
consent and the protocol was conducted in a manner ap- 
proved by a University of Toronto Ethics Review Commit- 
tee. On the basis of the aforementioned criteria, the patients 
we enrolled represented 37% of all patients admitted to our 
coronary care unit for management of unstable angina. All 
patients were followed up by one of five cardiologists at St. 
Michael’s Hospital, a tertiary care institution, whose ap- 
proach to management of unstable angina was standardized. 
For the purpose of this study, we examined all available 
ECG information from the time of qualifying chest pain to 
coronary care unit admission and selected the tracing with 
the most pronounced ST shift as the admission ECG. The 
standard protocol was to begin therapy with topical nitrates 
and calcium channel antagonists. Beta blockers were con- 
tinued if the patient had been taking them before admission 
or added if the patient was unresponsive to the aforemen- 
tioned therapy. 3 
ST segment monitoring. Twenty-four hour ST segment 
monitoring was begun 6.5 2 5.9 h after the qualifying 
episode of chest pain: the results were unavailable to the 
attending cardiologists. We used a two channel (leads V, and 
V,) on-line computer-based digital Holter system (Medi- 
camp, Epicardia HC) with a frequency response of 0.05 to 
100 Hz in accordance with American Heart Association 
standards (25). We have previously validated this Holter 
system by comparison with the Marquette CASE exercise 
computer system using measurements of maximal ST shift at 
rest, during maximal exercise and immediately after exercise 
in 21 patients with coronary artery disease (r = 0.92, 0.87 
and 0.94, respectively). Thirty-seven patients did not un- 
dergo Holter monitoring for technical reasons, and were 
excluded from subsequent analysis. Clinical outcome and 
coronary angiographic findings in these patients were not 
different from those in the rest of the group. 
Of the remaining 135 patients who constituted the study 
group (93 male and 42 female, mean age 57 ? 10 years), all 
had 24 h of ECG recording on one channel and ~16 h on the 
other. However, the majority of patients (86%) had 24 h of 
recording on both channels. An episode of ischemic ST shift 
from baseline was considered to be present if 2 1 mm (1 mm 
= 0.1 mV) ST elevation or horizontal or downsloping ST 
depression 80 ms from the J point was present for ~60 s. For 
consideration as inclusion criteria, episodes of ST shift had 
to be separated from each other by 210 min. 
Patients and attending nurses kept a careful diary of 
symptoms and they activated ST segment recording by 
pushing a button if chest discomfort was present. Silent 
ischemia was defined as occurrence of ischemic ST shift in 
the absence of symptoms. 
Heart rate and blood pressure monitoring. On admission 
to the coronary care unit, an intraarterial line was inserted 
for continuous monitoring of blood pressure. Heart rate and 
blood pressure changes were recorded at 1 min intervals and 
were printed out in 2 h trend records throughout the first 24 
h of admission. After excluding any hemodynamic perturba- 
tions occurring during ST shift, mean values for heart rate 
and blood pressure were determined during the 2 h period 
surrounding each episode of ST shift to serve as a baseline. 
The rate-pressure product was calculated at the onset and at 
20 and 10 min before the onset of ST segment shift, and the 
values were compared with the baseline rate-pressure prod- 
uct. 
Angiograpby. Selective coronary angiography was per- 
formed 4.2 2 2.6 days after admission. The severity of 
coronary artery stenosis was assessed in multiple views by 
three experienced independent observers who were unaware 
of the results of Holter ECG monitoring. A significant 
stenosis was considered present if there was ~50% narrow- 
ing of the lumen in the left anterior descending artery or its 
diagonal branch, the left circumflex artery or its obtuse 
marginal branches or the right coronary artery. 
Unfavorable outcome. Unfavorable hospital outcome was 
defined as myocardial infarction, death or need for urgent 
aortocoronary bypass or percutaneous transluminal coro- 
nary angioplasty because of recurrent prolonged symptoms 
at rest refractory to maximal medical therapy. 
Data analysis. Results are presented as mean values + 
SD. To address our study hypothesis, we initially related 
total duration of ST shift to the findings of unfavorable 
hospital outcome, multivessel disease or left main coronary 
stenosis by analysis of variance. Because of recent reports 
(21,22), and after prospective collection of data was com- 
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pleted, we also classified our patients into three groups with 
respect to duration of ST shift: Group I (no ST shift), Group 
II (1 to 59 min duration of ST shift) and Group III (~60 min 
of ST shift per 24 h of Holter monitoring). Because the 
distribution of ST shift duration was non-Gaussian, we 
performed log transformation for the purposes of statistical 
analysis. Comparison between groups with respect to base- 
line clinical characteristics was done by analysis of variance 
in the case of continuous variables and by chi-square anal- 
ysis in the case of discrete variables. Odds ratio and 95% 
confidence intervals for unfavorable outcome were calcu- 
lated in patients with ST shift on Holter monitoring. The best 
predictors of hospital outcome were determined by multiple 
regression analysis taking into account the clinical and 
laboratory variables of age, gender, history of hypertension, 
diabetes, previous myocardial infarction, smoking, number 
of episodes and duration of ischemic pain during the first 24 
h of admission, number of episodes and duration of all ST 
shift, number of episodes and duration of silent ischemia. 
presence or absence of ST shift on admission ECG and 
number of vessels with ~50% stenosis. 
Differences between symptomatic and asymptomatic ep- 
isodes as well as differences between the episodes with ST 
elevation and ST depression were compared with respect to 
duration and magnitude of ST shift with use of Student’s 
unpaired t test. Differences in rate-pressure product in 
relation to 2 h baseline measurement were compared with 
use of two-way analysis of variance and Dunnett’s test. The 
sensitivity of admission ECG and Holter monitor ECG with 
respect to unfavorable outcome was compared with use of 
McNemar’s test. 
Results 
The clinical and angiographic characteristics of our study 
group as well as the details of antianginal therapy during the 
first 24 h of the hemodynamic and Holter monitoring are 
shown in Table 1. During hospitalization, 10 patients (7%) 
had nonfatal myocardial infarction and 6 patients (4%) died 
(3 in the peri-operative period). Six patients (4%) underwent 
urgent coronary angioplasty and 40 (30%) underwent urgent 
aortocoronary bypass operations. Nonurgent coronary 
angioplasty and bypass procedures were performed in an 
additional 19 patients (14%) and were not considered as an 
unfavorable outcome. 
Admission electrocardiogram. Of the 135 patients, 34 
(25%) had ST depression, 21 (16%) had ST elevation and 5 
(4%) had both ST depression and ST elevation on the 
admission ECG. In comparison with patients who had iso- 
electric ST segments on the admission ECG, patients with 
ST depression on admission had a longer duration of ST shift 
on Holter monitoring (121 ? 145 versus 40 i 78 min, p < 
0.01) as did patients with ST elevation on admission (134 F 
147 versus 40 ? 78 min, p < 0.01). 
Table 1. Clinical and Angiographic Characteristics of 135 Patients 
With Unstable Angina 
Age (yr) 
Gender (male %i) 
Diabetes C’S) 
Smokers (%) 
Hypertension (%) 
Previous MI (%) 
Previous angina E%) 
Medications 
IV nitroglycerin (7%) 
All nitrates (‘%) 
Beta-blockers (%) 
Calcium antagonists (R) 
Aspirin (%) 
Coronary angiography 
0 Vessel disease W) 
I Vessel disease (‘7) 
2 Vessel disease (‘t) 
3 Vessel disease (%) 
Left main stenosis (7%) 
51 f 10 
69 
35 
37 
39 
61 
28 
80 
46 
74 
I2 
15.5 
15.5 
I8 
51 
I3 
IV = intravenous: MI = myocardial infarction. 
Holter ECG monitoring. Of the 135 patients, 89 (66%) 
had ST shift on Holter monitoring; 55 (62%) had ST depres- 
sion, 18 (20%) had ST elevation and 16 (18%) had both ST 
elevation and depression. In the 89 patients with ST shift, 
the mean baseline ST level during 24 h of Holter monitoring 
was -0.5 + 0.8 mm in lead V, and 0.2 2 0.7 mm in lead V,. 
The mean duration of ST shift in the 24 h period after 
admission was 119 5 133 min (range 1 to 577). There were a 
total of 593 episodes of ST shift with an average of 6.7 
episodes/patient (range 1 to 23). The duration of each epi- 
sode averaged 18 2 30 min (range 1 to 230). 
Among 135 patients, 62 were receiving a beta-adrenergic 
blocker while undergoing Holter monitoring. The duration of 
ST shift in these patients was similar to that of patients not 
receiving a beta-blocker (91 -+ 133 versus 68 2 110 min, p = 
NS). 
When patients were classified according to duration of ST 
shift, 46 had no ST shift (Group I), 44 had ST shift of 1 to 59 
min duration (Group II) and 45 patients had ST shift of 260 
min duration (Group III). 
Asymptomatic versus symptomatic ST shift. Of 89 pa- 
tients with ST shift on Holter ECG monitor, the majority 
(68%) had silent ischemia exclusively as compared with 6% 
of patients in whom the ST shift was always symptomatic. 
The remaining 26% of the patients had both symptomatic 
and asymptomatic ST shift. 
Among 593 episodes of ST shift on Holter ECG monitor- 
ing 547 (92%) were asymptomatic and 46 (8%) were symp- 
tomatic. The duration of symptomatic episodes was signifi- 
cantly longer than that of asymptomatic episodes (41 2 49 
versus 16 ? 27 min, p < 0.01). The difference in magnitude 
of ST shift between the symptomatic and asymptomatic 
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Table 2. Relation Between Rate-Pressure Product and ST Shift on Holter Monitoring 
Time of 2h 
Before ST Shift 
20 min 
70 * 14 
128 + 23 
9.1 2 2.6 
70 + 14 
129 + 22 
9.2 + 2.6 
68t II 
124 + 20 
8.6 k 2.2 
71 r 13 
125 + 20 
8.9 2 2.4 
702 13 
130 + 23 
9.2 + 2.7 
10 min 
12 ? 15 
130 ? 22 
9.4 ” 2.F 
72 + 15 
131 + 22 
9.4 r 2.1* 
71 + 11 
121 ? 17 
9.2 k 2.0 
12 ? 16 
126 2 20 
9.1 2 2.6 
72 + 14 
132 + 22 
9.5 + 2.F 
Onset of 
ST Shift 
71 + 16 
130 + 22 
9.3 ? 2.8* 
71 + 16 
130 t 22 
9.2 ? 2.8* 
72 2 12 
134 + 23 
9.9 f 2.6t 
71 k 17 
125 ? 22 
9.0 ? 2.1 
71 + 16 
132 + 22 
9.4 ? 2.8* 
Type of Episode 
All episodes (n = 446) 
Asymptomatic (n = 412) 
Symptomatic (n = 34) 
ST elevation (n = 140) 
ST depression (n = 306) 
Measurement 
HR 
SBP 
RPP 
HR 
SBP 
RPP 
HR 
SBP 
RPP 
HR 
SBP 
RPP 
HR 
SBP 
RPP 
Baseline 
70+ 13 
128 2 19 
9.0 2 2.3 
70* 14 
128 k 19 
9.0 + 2.3 
61 + 9 
128 2 19 
8.9 ? 2.0 
70 f 15 
125 + 19 
8.7 5 2.1 
70* 13 
130 + 19 
9.1 ? 2.4 
*p < 0.01; tp < 0.05. HR = heart rate (beatslmin); RPP = rate-pressure product (HR X BP X 103); SBP = 
systolic blood pressure (mm Hg). 
episodes was detected in episodes with ST depression 
(-1.8 ? 0.8 versus -1.3 k 0.4 mm, p < 0.01) as well as ST 
elevation (2.5 + 1.8 versus 1.4 2 0.7 mm, p < 0.01). When 
asymptomatic episodes in patients with both symptomatic 
and asymptomatic episodes were compared with asympto- 
matic episodes in patients who had only asymptomatic 
episodes, no difference was found with respect to duration 
(14 + 17 versus 16 k 29 min, p = NS) or magnitude of ST 
shift (1.4 + 0.6 versus 1.3 + 0.4 mm, p = NS). Both 
symptomatic and asymptomatic episodes were predomi- 
nantly associated with ST depression, (72% and 67%, re- 
spectively, p = NS). 
ST depression versus ST elevation. Of 593 episodes of ST 
shift, in 405 (68%) the ST segment was depressed and in 188 
(32%) it was elevated. Episodes with ST elevation were 
similar in duration to those with ST depression (17 +- 30 
versus 18 2 30 min, p = NS); however, they were associated 
with greater magnitude of ST shift when compared with 
episodes with ST depression (1.5 k 0.9 versus 1.3 5 0.5 mm, 
p < 0.01). 
Patients exhibiting either ST depression or ST elevation, 
or both, on Holter monitoring were not different with respect 
to frequency of multivessel disease (71%, 72% and 94%, 
respectively), left main stenosis (16%, 11% and 31%) or 
unfavorable outcome (46%, 50% and 62%). The occurrence 
of ST shift on the Holter ECG monitor was independent of 
previous myocardial infarction; 41% of patients with ST shift 
had previous myocardial infarction as compared with 35% of 
patients without ST shift (p = NS). There was also no 
difference in frequency of previous myocardial infarction 
between patients with ST elevation and those with ST 
depression on Holter monitoring. 
Heart rate and blood pressure monitoring (Table 2). In 
446 episodes of ST shift, heart rate, blood pressure and 
rate-pressure product records were available for analysis. 
These were recorded during a 2 h baseline period, at 20 and 
10 min before the onset of ST shift and at the onset of ST 
shift. When all episodes were considered, there was a slight 
but significant rise in rate-pressure product 10 min before the 
onset of ST shift as compared with baseline. Rate-pressure 
product at the time of onset of ST shift was also higher than 
at baseline but showed no further increase when compared 
with the value 10 min before the onset of ST shift. When 
episodes were classified according to the presence or ab- 
sence of symptoms, or the presence of ST elevation or ST 
depression, a similar trend of increasing rate-pressure prod- 
uct before the onset of ST shift was noted. 
To evaluate the maximal changes in rate-pressure prod- 
uct during each episode of ST shift, we compared the 2 h 
baseline value with that recorded either at 10 min before the 
ST shift or at its onset (Fig. 1). The increase in rate-pressure 
product was > 10% in >40% of episodes and >20% in > 17% 
of episodes. The mean change in rate-pressure product was 
an increase of 10 2 15% and the median change was an 
increase of 7%. The rise in rate-pressure product during 
symptomatic episodes was substantially greater than that 
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% change in RPP 
Figure 1. Distribution of 446 episodes with ST segment shift ac- 
cording to maximal percent change in rate-pressure product (RPP) 
(at either the onset of ST shift or 10 min before its onset) compared 
with the value at 2 h baseline. 
seen during asymptomatic episodes (17 ? 20% versus 10 2 
15%, p < 0.05); the majority of this change occurred at the 
time of onset of ST shift. To partition the influence of 
symptoms on rate-pressure product changes during sympto- 
matic ST shift, we also evaluated the changes during epi- 
sodes of chest pain not associated with ST shift; we found no 
significant increase in rate-pressure product from baseline. 
Coronary angiography. Multivessel disease was present 
in 93 patients (69%) and left main stenosis was found in 18 
(13%) (Table 1). More patients with ST depression on the 
admission ECG had multivessel disease then did those with 
no ST shift (77% versus 63%, p < 0.05); similarly, left main 
stenosis was more frequent when ST depression was present 
on admission ECG (28% versus 7%, p < 0.025). Patients 
with ST elevation on the admission ECG had the same 
frequency of multivessel disease and left main stenosis as did 
those with no ST shift (69% versus 63% and 15% versus 7%, 
respectively, p = NS). 
Patients with multivessel disease, as compared with 
patients without multivessel disease, had a longer duration 
of ST shift on the Holter monitor (98 t 129 versus 36 rf: 90 
min, p < O.Ol), more frequent episodes of ST shift (7.3 of: 5.2 
versus 4.5 ? 3.4 episodes, p < 0.05) and a longer duration of 
ST shift per episode (18 2 12 versus 11 t 11 min, p < 0.05). 
The duration of ST shift was also longer in those patients 
with versus those without left main stenosis (150 2 147 
versus 67 + 114 min, p < 0.01). 
In comparison with patients without ST shift (Group I), 
the 89 patients with ST shift on Holter monitoring (Groups II 
and III) were found to have a higher frequency of multivessel 
disease (76% versus 54%, p < 0.01) and left main stenosis 
(18% versus 4%, p < 0.05). Patients in Group III (ST shift 
~60 min) had a significantly greater incidence of multivessel 
disease (89%) and left main stenosis (27%) as compared with 
patients in Group 1(54% and 4%, respectively, p < 0.025) or 
Group II (ST shift ~60 min) (64% and 9%, respectively, p < 
0.05). No intergroup differences were evident with respect to 
baseline clinical characteristics (Table 1) or in time to the 
start of Holter monitoring. Before admission, more patients 
in Group III (76%) were taking nitrates than were those in 
Group I (48%, p < 0.025) or Group II (52%. p < 0.05) and 
more in Group III (76%) were taking a calcium antagonist 
than were those in Group II (43%, p < 0.005). During Holter 
monitoring, more patients in Group III (89%) were taking a 
calcium antagonist than were those in Group I (65%, p < 
0.025) or Group II (68%, p < 0.05). 
Unfavorable hospital outcome. Of the 13.5 patients, 52 had 
an unfavorable outcome that occurred at a mean of 4.5 -t 3.2 
days. Compared with the other 83 patients, those with an 
unfavorable outcome were taking more antianginal medica- 
tions (2.6 ? 0.5 versus 2.3 t 0.8 drugs/person, p < 0.01). 
These medications consisted of nitrates in all patients, a 
calcium antagonist in 98% and a beta-blocker in 65% of 
patients. 
An unfavorable outcome was more frequent in patients 
with ST depression (56%) or ST elevation (54%) than in 
patients with no ST shift on the admission ECG, (25%, p < 
0.01 and p < 0.05, respectively). Patients with an unfavor- 
able outcome had a longer duration of ST shift on the Holter 
monitor (129 + 136 versus 52 + 111, p < O.Ol), more 
frequent episodes of ST shift (7.0 t- 5.9 versus 2.9 f 3.9. 
p < 0.01). and longer duration of ST shift per episode (16 ? 
14 versus 7 ? 11 min, p < 0.01). Patients with ST shift on the 
Holter monitor had a more frequent unfavorable outcome 
when compared with those with no ST shift (48% versus 
20%, p < 0.005; odds ratio 3.79 with 95% confidence interval 
from 1.62 to 8.89). Patients in Group III (ST shift 260 min) 
had an increased incidence of unfavorable outcome (67%) as 
compared with that in patients in Group I (no ST shift) (20%, 
p < 0.025; odds ratio 8.83 with 95% confidence interval from 
5.39 to 12.88) or Group II (ST shift ~60 min) (30%, p < 0.05; 
odds ratio 4.52 with 95% confidence interval from 1.76 to 
11.6). 
Recognizing that the basis for recommending coronary 
revascularization has a subjective component, we also ana- 
lyzed the results of Holter monitoring using only “hard” end 
points, that is, nonfatal myocardial infarction and death. 
Patients with these end points had a significantly longer 
duration of ST shift than did patients without these end 
points (147 f. 137 versus 69 -C 117 min. p < 0.05). Patients in 
Group III (ST shift ~60 min) had more frequent nonfatal 
myocardial infarction and death than did patients in Group I 
(no ST shift) (20% versus 4%, p < 0.05). No difference was 
found between Groups III and II (ST shift ~60 min) (20% 
versus 1 I%, p = NS) or Groups II and I (11% versus 4%, 
p = NS). 
Patients with an unfavorable outcome had a slightly 
greater ST shift when compared with patients who did not 
have an unfavorable outcome (1.5 + 0.8 versus 1.3 ? 0.4 
mm, p < 0.01). 
There was a good correlation between the duration of ST 
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shift and the frequency of episodes of ST shift in our study 
(r = 0.90). There was no difference in positive predictive 
value of r5 episodes of ST shift versus duration of ~60 min 
with respect to unfavorable outcome (63% versus 67%), 
multivessel disease (85% versus 89%) and left main stenosis 
(23% versus 26%). 
Seventy-four of 135 patients had recurrent chest pain in 
the first 24 h after admission. ST shift on Holter monitoring 
occurred in 69% of these and in 62% of patients without 
recurrent chest pain (p = NS). Sixty-five percent of patients 
with recurrent chest pain that was not associated with ST 
shift had a normal admission ECG, and this group had a 
similar frequency of unfavorable outcome as patients with- 
out recurrent chest pain. However, more patients with 
recurrent chest pain associated with any ST shift during 
Holter monitoring had an unfavorable outcome than did 
patients with an ST shift alone (69% versus 4l%, p < 0.025). 
We used a multiple regression model to define the best 
predictors of unfavorable outcome. Of 14 clinical and labo- 
ratory variables, coronary anatomy on angiography was 
found to be the best predictor (F = 44.3, p < 0.0001). When 
the results of angiography were removed from the model, the 
duration of ST shift on Holter recording was found to be the 
best predictor of unfavorable outcome (F = 18.1, p < 
0.0001). The third best predictor of unfavorable outcome 
was age (F = 10.43, p < 0.001). 
The admission ECG was less sensitive than was Holter 
ECG monitoring in identibing patients with unfavorable 
outcome (63% versus 83%, respectively, p < 0.005). Among 
the 52 patients with an unfavorable hospital outcome, 33 
were identified by the presence of ST shift on the admission 
ECG; the results of Holter monitoring in these patients did 
not further increase the sensitivity. By contrast, in 75 
patients without ST shift on the admission ECG, Holter 
monitoring identified an additional 15 patients with an unfa- 
vorable outcome. Hence, only 4 of 52 patients with an 
unfavorable outcome did not have ST shift on either the 
admission ECG or Holter ECG monitoring. 
Among the 93 patients with multivessel disease, the 68 
patients with ST shift on Holter monitoring more frequently 
had an unfavorable outcome as compared with the 25 
patients with no ST shift (62% versus 28%, p < 0.01). Thus, 
the presence of ST shift on Holter monitoring was helpful in 
identifying patients with an unfavorable outcome both be- 
fore and after the results of coronary angiography were 
available. 
Discussion 
Our study provides new and comprehensive information 
relating the analysis of ST shift on the admission ECG and 
24 h Holter ECG monitoring to angiographic characteristics 
and hospital outcome in patients with unstable angina. We 
also present new data on analysis of hemodynamic changes 
in association with episodes of ST shift in these patients. 
Admission ECG. The significance of the admission ECG 
with respect to presence or absence of ST shift in patients 
with unstable angina has not been previously evaluated. 
Earlier studies assessing the treatment of unstable angina 
(17) and the value of Holter monitoring (21,22) have used ST 
shift on the admission ECG as part of study entry criteria. 
This procedure creates a selection bias and precludes the 
capacity to assess the prognostic value of the admission 
ECG. Despite a careful search for ST shift, we found that 
only 44% of the 135 patients had ST segment depression or 
elevation on the admission ECG and these patients more 
frequently had an unfavorable outcome than did those who 
had isoelectric ST segments. However, because attending 
cardiologists were aware of the results of the admission 
ECG, their patient management and, in particular, the deci- 
sion to recommend revascularization may have been influ- 
enced by this information. 
Patients with ST shift on the admission ECG also had a 
longer duration of ST shift on Holter monitoring when 
compared with patients with normal ST segments on admis- 
sion. In fact, the presence of ST shift on the admission ECG 
had a positive predictive value of 80% for finding ST shift on 
Holter monitoring. Despite the prognostic value of the 
admission ECG, among patients with a normal admission 
ECG, 25% had an unfavorable outcome, 63% had multives- 
se1 disease and 7% had left main stenosis. 
Halter ECG monitoring. Previous studies (21,22) have 
shown that an arbitrary classification of silent ischemia 260 
min in duration is associated with an unfavorable 1 and 6 
month prognosis. In addition to demonstrating that the 
presence of any ST shift, silent or symptomatic, predicts 
unfavorable hospital outcome, our study provides a prospec- 
tive validation of the use of ST shift of 260 min duration as 
a criterion for unfavorable outcome. 
Our finding of more frequent multivessel disease and left 
main stenosis in patients with 260 min ST shift is similar to 
that of Nademanee et al. (22) but different from the data of 
Gottlieb et al. (21). The smaller number of patients and 
incomplete angiographic data in the latter study may account 
for the differences observed. 
The signijkance of ST elevation versus ST depression in 
patients with unstable angina has not been previously ad- 
dressed. We found no differences between these variables in 
duration of ST shift or association with occurrence of 
multivessel disease, left main stenosis and unfavorable out- 
come. Episodes of ST elevation, however, were less fre- 
quent than episodes of ST depression and were associated 
with a greater magnitude of ST shift. The reasons for 
occurrence of ST elevation versus ST depression remain 
unclear. 
The relative frequency of asymptomatic ST shift was 
similar to that found in previous studies (21,22); however, 
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previous studies did not compare symptomatic and asymp- 
tomatic episodes. We found that symptomatic episodes were 
of longer duration and had a greater magnitude of ST shift 
than did asymptomatic episodes. This new and important 
finding suggests that episodes of symptomatic ST shift on 
Holter monitoring are associated with a greater extent of 
myocardial ischemia as compared with episodes of silent 
ischemia. However, symptomatic episodes constituted a 
small minority (8%) of all episodes of ST shift. Importantly, 
it was the total duration of ST shift (symptomatic and 
asymptomatic) that was associated with multivessel disease, 
left main stenosis or unfavorable hospital outcome. In fact, 
duration of ST shift on Holter ECG monitoring was the best 
noninvasive predictor of unfavorable outcome when all the 
other conventional factors were taken into account. 
Rate-pressure product and ST shift. Assessment of he- 
modynamic changes in relation to onset of myocardial isch- 
emia has been addressed in two previous studies (26,27). 
Maseri et al. (27) studied 22 patients with vasospastic angina 
at rest and found no increase in heart rate or blood pressure 
preceding the episodes of ST shift. Cannom et al. (26) 
studied patients with unstable angina and found that some 
had an increase in rate-pressure product in association with 
angina1 episodes. Because Holter monitoring was not per- 
formed and hemodynamic monitoring was intermittent, they 
did not assess the exact sequence of hemodynamic changes 
preceding the onset of myocardial ischemia. A strength of 
our study is that we continuously monitored heart rate and 
blood pressure throughout the period of Holter monitoring 
and, therefore, were able to study changes in rate-pressure 
product both before and at the time of onset of ST shift. We 
found a slight, but significant increase in rate-pressure prod- 
uct preceding the onset of ST shift and propose that small 
increases in myocardial oxygen demand may provoke myo- 
cardial ischemia in at least some patients with unstable 
angina and severe impairment of coronary flow. Given that a 
substantial number of episodes of ST shift had either no 
change or a decline in rate-pressure product in association 
with ST shift (Fig. I), a primary reduction in myocardial 
perfusion was likely also an important factor. Because we 
did not measure coronary blood flow, the relative contribu- 
tions of myocardial oxygen delivery and oxygen demand as 
modulators of ischemia could not be directly evaluated. 
Symptomatic versus asymptomatic episodes. Sympto- 
matic episodes of ST shift were associated not only with a 
greater duration and magnitude of ST shift, as compared 
with asymptomatic episodes, but also with a greater increase 
in rate-pressure product at the time of onset of ST shift. It is 
possible that this increase was a result of sympathetic 
stimulation secondary to symptoms. However, our finding 
that a significant increase in rate-pressure product occurred 
in association with asymptomatic episodes but did not occur 
during episodes of chest pain without ST shift lends support 
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to the potential pathogenetic role of an increase in myocar- 
dial oxygen demand in symptomatic patients with ST shift. 
In summary, our data, drawn from a broad cross section 
of patients with unstable angina and normal or abnormal 
findings on the admission ECG, indicate that, although 
symptomatic ST shift is associated with a greater extent of 
myocardial ischemia, symptoms alone are an inadequate 
guide for management of patients with unstable angina. 
When both ischemic pain and ST shift are present, however, 
severe coronary artery disease and poor hospital outcome 
are more frequent. Monitoring of either the duration or the 
number of episodes of ST segment shift provides a better 
assessment of the total ischemic burden than does angina 
alone. The presence of ST shift should alert the physician to 
intensify medical therapy or to perform coronary angiogra- 
phy to identify those patients who have multivessel disease 
or left main stenosis who may be better served by revascu- 
larization. When health resources are limited, physicians 
should first identify those patients with ST shift on the 
admission ECG because they have an increased frequency of 
multivessel disease, left main stenosis and unfavorable hos- 
pital outcome. In patients without ST shift on admission, 
Holter monitoring will help to identify those with severe 
coronary artery disease and unfavorable hospital outcome. 
The results of Holter monitoring are of additional prognostic 
value in patients who are found to have multivessel disease. 
Our findings indicate thut in patients with unsfahle an- 
gina: 1) analysis of the ST segment on the admission ECG 
and Holter ECG monitoring can stratify patients with unsta- 
ble angina into prognostic subsets with respect to unfavor- 
able hospital outcome and coronary anatomy; 2) when 
episodes of ST shift are associated with symptoms, the shift 
is of greater magnitude and of longer duration; 3) myocardial 
ischemia. as demonstrated by the onset of ST shift, may be 
mediated in part by increased myocardial oxygen demand, 
as defined by an increase in rate-pressure product. 
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